Navigation Links
Methadone & Metabolite Confirmation/Quantitation, Serum or Plasma

ProductsMethadone & Metabolite Confirmation/Quantitation, Serum or Plasma
Company ARUP Laboratories
Item Methadone & Metabolite Confirmation/Quantitation, Serum or Plasma
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Methadone - Rapid Test
2. Drugs of Abuse Confirmation/Quantitation-Methadone & Metabolite-Serum or Plasma
3. Drugs of Abuse Confirmation/Quantitation-Methadone & Metabolite-Meconium
4. Drugs of Abuse Confirmation/Quantitation-Methadone & Metabolite-Urine
5. Meconium, Methadone & MetaboliteConfirmation/Quantitation
6. Methadone & Metabolite Confirmation/Quantitation, Urine
7. Methadone & Metabolite Confirmation/Quantitation, Meconium
8. SureStep Methadone (MTD)
9. Drugs of Abuse Array Cocaine Metabolite Assay
10. Amiodarone & Metabolite
11. Amoxapine & Metabolite, Serum or Plasma
EZ-PSA is a one-step immunoassay for the rapid, qualitative determination of human Prostate Specific Antigen (PSA) in whole blood. The test is intended for professional use as an aid in the diagnosis...
... derives its name from its first known ... The majority of PSA circulates bound to ... concentrations of PSA are elevated in patients ... and prostatitis [1-3]. In addition, PSA serum ...
... of Vision and Contrast Sensitivity. The ... and glare luminance levels for accurate ... with/without glare and background luminance Comply ... standards. All Light Levels Microprocessor Controlled ...
Contrast Sensitivity is Recognized as a Valuable Tool for Measuring Functional Vision Loss Caused by Early Eye Disease. Distance Test S.W.C.T. 201: Size 27in x 37 in (68.58cm x 93.98cm),Can be Wal...
Medicine Products:
(Date:2/28/2015)... 2015 For those people who are ... Mesothelioma Applied Research Foundation (Meso Foundation) will ... 3, starting at 9:30 AM. , The live broadcast ... broadcast can be accessed through any browser on a ... The Symposium is a unique event that covers important ...
(Date:2/28/2015)... Dr. Perry Patel , a ... recently announced a special offer for the Zoom!® Chairside ... for new and established patients at his Pismo Beach dentist office. ... white smile, Dr. Patel and his staff are offering ... from the regular price of $450. , Zoom! whitening ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 How ... Supportive? Strategic? , There are all kinds of ... To raise awareness of the advantages and applications ... PeopleKeys is launching a new product this spring ... better understand the connection between personality type, leadership, ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Developers of ... of a new overlay plugin for Final Cut Pro X ... , “FCPX Overlay Chromatic gives users total control over 6k ... Austin, CEO of Pixel Film Studios. “FCPX Overlay Chromatic was ... easy to use interface.” , FCPX Overlay Chromatic Grunge 6K ...
(Date:2/28/2015)... 2015 Memphis, TN: MedixSafe has retracted ... a new security reader named Guardian 2. The ... a new biometric scanner that significantly increases the ... the new biometric scanner provides fast and easy ... MedixSafe narcotics lockers with Vanguard technology ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2
... CARLOS, Calif., Nov. 7 Nektar,Therapeutics (Nasdaq: NKTR ... quarter that ended September 30, 2007. Revenue totaled ... to,$58.6 million in the third quarter of 2006. For ... revenue of $207.3 million,compared to $147.8 million in the ...
... Nov. 7 Rapid Pathogen Screening Inc.,(RPS) -- ... ocular,diseases -- announced today that the American Medical ... code that will cover the,RPS Adeno Detector(TM), effective ... code,for "Infectious agent antigen detection by immunoassay with ...
... 7 Mesa Laboratories,Inc. (Nasdaq: MLAB ) today reported ... and six months ended September 30, 2007. Highlights: ... * Second quarter net income increases 40% ... the second quarter of fiscal 2008, net sales increased 16 ...
... Corrective cardiac surgery is not to blame, study suggests , , ... in babies born with certain heart defects, new research shows. ... delay found in premature infants, the researchers added. , Babies ... developmental delays, but whether the delays were due to the ...
... This past weekend study,results on "Molecular Breast ... at the Nuclear Science Symposium and Medical,Imaging Conference ... laboratory study was to evaluate the performance of ... in which,the two imaging detectors are positioned on ...
... 7 Today, the release of,Emerging Answers 2007: ... Sexually Transmitted Disease, a report authored by Douglas,Kirby, ... once,again, that the $1.5 billion federal and state ... money., The report, commissioned by the National ...
Cached Medicine News:Health News:Nektar Therapeutics Announces Third Quarter 2007 Financial Results 2Health News:Nektar Therapeutics Announces Third Quarter 2007 Financial Results 3Health News:Nektar Therapeutics Announces Third Quarter 2007 Financial Results 4Health News:Nektar Therapeutics Announces Third Quarter 2007 Financial Results 5Health News:Nektar Therapeutics Announces Third Quarter 2007 Financial Results 6Health News:Nektar Therapeutics Announces Third Quarter 2007 Financial Results 7Health News:American Medical Association Clears Path for Adenoviral Conjunctivitis - 'Pink Eye' - Detector 2Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 2Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 3Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 4Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 5Health News:Heart Defects Can Delay Baby's Brain Development 2Health News:Heart Defects Can Delay Baby's Brain Development 3Health News:Heart Defects Can Delay Baby's Brain Development 4Health News:Dilon Technologies Explores Improvements in Molecular Breast Imaging 2Health News:Dilon Technologies Explores Improvements in Molecular Breast Imaging 3Health News:New Study - Same Verdict 2
(Date:2/27/2015)... YORK , Feb. 27, 2015 Securities ... the board of Salix Pharmaceuticals, Ltd. (NASDAQ: ... $158.00 per share. Concerned SLXP investors are encouraged to ... The investigation focuses upon the shareholder ... agreement, Salix shareholders would receive only $158.00 per share ...
(Date:2/27/2015)... Report Details   ... R&D progress, and predicted revenues ,Where is the market ... commercial prospects for this market and related technologies? Visiongain,s ... trends to 2025, discussing data, opportunities and prospects. ... regenerative medicine : cell-based therapies that aim to restore ...
(Date:2/27/2015)... , Feb. 27, 2015  Organovo Holdings, ... company focused on delivering breakthrough 3D bioprinting technology, ... and Chief Executive Officer, will present live at ... invite you to join us for this Company ... updates on our commercial launch of the exVive3D ...
Breaking Medicine Technology:Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4